When is active surveillance indicated in the treatment of renal cell carcinoma (RCC)?

Updated: Jun 08, 2020
  • Author: Kush Sachdeva, MD; Chief Editor: E Jason Abel, MD  more...
  • Print

According to the 2009 AUA management guideline, active surveillance is a reasonable choice for the management of localized renal masses. The AUA guideline recommends active surveillance as an option for all patients. For patients with decreased life expectancy or numerous comorbidities that would make them high risk for intervention, active surveillance is recommended as first choice.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!